ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMFlussi di cassa derivanti dalle attività di investimento-17.84 K-24.89 K-1-289.58 K-40.54 K-355.01 KLiquidità derivante dalle attività di finanziamento-161.76 K-166.19 K-42.89 M-403.48 K-87.82 K-43.55 MLiquidità libera56.29 M7.04 M63.08 M-10.1 M-16.9 M43.12 M
SIGA Technologies Inc
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.